18 results
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
; created a new Patient Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness … potentially increasing a manufacturer’s Medicaid rebate liability;
a Patient-Centered Outcomes Research Institute to oversee, identify priorities
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
and transaction expertise to oversee the further refinement of our resources and our timeline towards monetizing these assets at the optimal time – Rubric’s … degrade our Board’s breadth of experience and ability to oversee our strategy. Rubric’s proposal would remove two public biotech company CEOs, two
6-K
EX-99.1
pg55gpsq8vdjdh
27 Mar 20
Business Update and Directorate Change
9:09am
F-1/A
f8bovp7o5f86h
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
ti5dg1cg3 dmu5
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
20-F
bmejwynjk0u0yrphb69
29 Apr 19
Annual report (foreign)
4:59pm
424B3
lg9u ji5os
20 Mar 19
Prospectus supplement
4:58pm
F-4/A
dtx910lih62 0ho
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
F-4
EX-10.5
tsh4juh831j
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
kccwoeqcrc82l8hl
25 Jan 19
Registration of securities (foreign)
12:00am
- Prev
- 1
- Next